The association of nonalcoholic fatty liver disease with central and peripheral blood pressure in adolescence: Findings from a cross-sectional study

Journal of Hypertension

Volumn 33, Issue 3, 2015, Pages 546-553

  Patel, Sumaiya ^a   Lawlor, Debbie A ^a   Ferreira, Diana L S ^a   Hughes, Alun D ^b   Chaturvedi, Nish ^b   Callaway, Mark ^c   Day, Chris ^d   Sattar, Naveed ^e   Fraser, Abigail ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Avon Longitudinal Study of Parents and Children; blood pressure; children; nonalcoholic fatty liver disease; obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; BIOLOGICAL MARKER;

ADOLESCENT; ADOLESCENT DISEASE; AGE DISTRIBUTION; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUGMENTATION INDEX; CHILDHOOD OBESITY; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FAT MASS; FATTY LIVER; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HEART RATE; HUMAN; LIVER FIBROSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROSPECTIVE STUDY; PUBERTY; PULSE PRESSURE; SEX DIFFERENCE; SOCIAL CLASS; SYSTOLIC BLOOD PRESSURE; ULTRASOUND; UNITED KINGDOM; BLOOD; BLOOD PRESSURE; DIAGNOSTIC IMAGING; ECHOGRAPHY; OBESITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

ADIPOSITY; ADOLESCENT; ALANINE TRANSAMINASE; ASPARTATE AMINOTRANSFERASES; BIOMARKERS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HUMANS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; OBESITY; RISK FACTORS; ULTRASONOGRAPHY;

EID: 84922464411     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000445     Document Type: Article

References (44)

1. Angulo P. Nonalcoholic fatty liver disease. N Engl J Med 2002; 346:1221-1231
2. Ghouri N, Preiss D, Sattar N. Liver enzymes, nonalcoholic fatty liver disease, and incident cardiovascular disease: a narrative review and clinical perspective of prospective data. Hepatology 2010; 52:1156-1161
3. Fraser A, Harris R, Sattar N, Ebrahim S, Smith GD, Lawlor DA. Gammaglutamyltransferase is associated with incident vascular events independently of alcohol intake: analysis of the British women's heart and health study and meta-analysis. Arterioscler Thromb Vasc Biol 2007; 27:2729-2735
4. Targher G, Day CP, Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010; 363:1341-1350
5. Targher G, Bertolini L, Padovani R, Rodella S, Zoppini G, Zenari L, et al. Relations between carotid artery wall thickness and liver histology in subjects with nonalcoholic fatty liver disease. Diabetes Care 2006; 29:1325-1330
6. Schindhelm RK, Diamant M, Bakker SJ, Van Dijk RA, Scheffer PG, Teerlink T, et al. Liver alanine aminotransferase, insulin resistance and endothelial dysfunction in normotriglyceridaemic subjects with type 2 diabetes mellitus. Eur J Clin Invest 2005; 35:369-374
7. Villanova N, Moscatiello S, Ramilli S, Bugianesi E, Magalotti D, Vanni E, et al. Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver disease. Hepatology 2005; 42:473-480
8. Chatrath H, Vuppalanchi R, Chalasani N. Dyslipidemia in patients with nonalcoholic fatty liver disease. Semin Liver Dis 2012; 32:22-29
9. Speliotes EK, Massaro JM, Hoffmann U, Vasan RS, Meigs JB, Sahani DV, et al. Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham heart study. Hepatology 2010; 51:1979-1987
10. Bedogni G, Miglioli L, Masutti F, Tiribelli C, Marchesini G, Bellentani S. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study. Hepatology 2005; 42:44-52
11. Lawlor DA, Callaway M, Macdonald-Wallis C, Anderson E, Fraser A, Howe LD, et al. Nonalcoholic fatty liver disease, liver fibrosis, and cardiometabolic risk factors in adolescence: a cross-sectional study of 1874 general population adolescents. J Clin Endocrinol Metab 2014; 99:E410-E417
12. Lawes CM, Bennett DA, Parag V, Woodward M, Whitlock G, Lam TH, et al. Blood pressure indices and cardiovascular disease in the Asia Pacific region: a pooled analysis. Hypertension 2003; 42:69-75
13. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med 1993; 153:598-615
14. Lawlor DA, Davey Smith G. Early life determinants of adult blood pressure. Curr Opin Nephrol Hypertens 2005; 14:259-264
15. Nelson MJ, Ragland DR, Syme SL. Longitudinal prediction of adult blood pressure from juvenile blood pressure levels. Am J Epidemiol 1992; 136:633-645
16. Gray L, Lee IM, Sesso HD, Batty GD. Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: Hahs (Harvard alumni health study). J Am Coll Cardiol 2011; 58:2396-2403
17. Roman MJ, Devereux RB, Kizer JR, Lee ET, Galloway JM, Ali T, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the strong heart study. Hypertension 2007; 50:197-203
18. Vlachopoulos C, Aznaouridis K, O'Rourke MF, Safar ME, Baou K, Stefanadis C. Prediction of cardiovascular events and all-cause mortality with central haemodynamics: a systematic review and meta-analysis. Eur Heart J 2010; 31:1865-1871
19. McEniery CM, Yasmin. Hall IR, Qasem A, Wilkinson IB, Cockcroft JR, Investigators A. Normal vascular aging: differential effects on wave reflection and aortic pulse wave velocity: the Anglo-Cardiff collaborative trial (acct). J Am Coll Cardiol 2005; 46:1753-1760
20. Targher G, Bertolini L, Rodella S, Zoppini G, Zenari L, Falezza G. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease. Clin Endocrinol (Oxf) 2006; 64:337-341
21. Lopez-Suarez A, Guerrero JM, Elvira-Gonzalez J, Beltran-Robles M, Canas-Hormigo F, Bascunana-Quirell A. Nonalcoholic fatty liver disease is associated with blood pressure in hypertensive and nonhypertensive individuals from the general population with normal levels of alanine aminotransferase. Eur J Gastroenterol Hepatol 2011; 23:1011-1017
22. Oh SY, Cho YK, Kang MS, Yoo TW, Park JH, Kim HJ, et al. The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease. Metabolism 2006; 55:1604-1609
23. Stranges S, Trevisan M, Dorn JM, Dmochowski J, Donahue RP. Body fat distribution, liver enzymes, and risk of hypertension: evidence from the western New York study. Hypertension 2005; 46:1186-1193
24. Alp H, Karaarslan S, Selver Eklioglu B, Atabek ME, Altin H, Baysal T. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents. Can J Cardiol 2013; 29:1118-1125
25. Pacifico L, Anania C, Martino F, Cantisani V, Pascone R, Marcantonio A, Chiesa C. Functional and morphological vascular changes in pediatric nonalcoholic fatty liver disease. Hepatology 2010; 52:1643-1651
26. Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 2008; 118:277-283
27. Sert A, Aypar E, Pirgon O, Yilmaz H, Odabas D, Tolu I. Left ventricular function by echocardiography, tissue Doppler imaging, and carotid intima-media thickness in obese adolescents with nonalcoholic fatty liver disease. Am J Cardiol 2013; 112:436-443
28. Singh GK, Vitola BE, Holland MR, Sekarski T, Patterson BW, Magkos F, Klein S. Alterations in ventricular structure and function in obese adolescents with nonalcoholic fatty liver disease. J Pediatr 2013; 162:1160-1168
29. Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J, et al. Cohort profile: the 'children of the 90s' - The index offspring of the Avon longitudinal study of parents and children. Int J Epidemiol 2013; 42:111-127
30. Fraser A, Macdonald-Wallis C, Tilling K, Boyd A, Golding J, Davey Smith G, et al. Cohort profile: the Avon longitudinal study of parents and children: Alspac mothers cohort. Int J Epidemiol 2013; 42:97-110
31. Saunders JB, Aasland OG, Babor TF, De la Fuente JR, Grant M. Development of the alcohol use disorders identification test (audit):who collaborative project on early detection of persons with harmful alcohol consumption - ii. Addiction 1993; 88:791-804
32. Vajro P, Lenta S, Socha P, Dhawan A, McKiernan P, Baumann U, et al. Diagnosis of nonalcoholic fatty liver disease in children and adolescents:position paper of the Espghan Hepatology Committee. J Pediatr Gastroenterol Nutr 2012; 54:700-713
33. Marginean CO, Marginean C. Elastographic assessment of liver fibrosis in children: a prospective single center experience. Eur J Radiol 2012; 81:e870-e874
34. Noruegas MJ, Matos H, Goncalves I, Cipriano MA, Sanches C. Acoustic radiation force impulse-imaging in the assessment of liver fibrosis in children. Pediatr Radiol 2012; 42:201-204
35. National High Blood Pressure Education Program Working Group on High Blood Pressure in C, Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents [4th report]. Pediatrics 2004; 114 (Suppl 2):555-576
36. Hughes AD, Park C, Davies J, Francis D, Mc GTSA, Mayet J, Parker KH. Limitations of augmentation index in the assessment of wave reflection in normotensive healthy individuals. PLoS One 2013; 8:e59371
37. Rubin DB. Multiple imputation after 18 years. J Am Stat Assoc 1996; 91:473-489
38. Dart AM, Kingwell BA. Pulse pressure - a review of mechanisms and clinical relevance. J Am Coll Cardiol 2001; 37:975-984
39. Charakida M, Jones A, Falaschetti E, Khan T, Finer N, Sattar N, et al. Childhood obesity and vascular phenotypes: a population study. J Am Coll Cardiol 2012; 60:2643-2650
40. Corden B, Keenan NG, De Marvao AS, Dawes TJ, Decesare A, Diamond T, et al. Body fat is associated with reduced aortic stiffness until middle age. Hypertension 2013; 61:1322-1327
41. Caserta CA, Pendino GM, Amante A, Vacalebre C, Fiorillo MT, Surace P, et al. Cardiovascular risk factors, nonalcoholic fatty liver disease, and carotid artery intima-media thickness in an adolescent population in southern Italy. Am J Epidemiol 2010; 171:1195-1202
42. Huang RC, Beilin LJ, Ayonrinde O, Mori TA, Olynyk JK, Burrows S, et al. Importance of cardiometabolic risk factors in the association between nonalcoholic fatty liver disease and arterial stiffness in adolescents. Hepatology 2013; 58:1306-1314
43. Giannini EG, Testa R, Savarino V. Liver enzyme alteration: a guide for clinicians. CMAJ 2005; 172:367-379
44. Preiss D, Sattar N. Nonalcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations. Clin Sci (Lond) 2008; 115:141-150